577 related articles for article (PubMed ID: 27404485)
1. p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.
Taniguchi K; Yamachika S; He F; Karin M
FEBS Lett; 2016 Aug; 590(15):2375-97. PubMed ID: 27404485
[TBL] [Abstract][Full Text] [Related]
2. p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells.
Umemura A; He F; Taniguchi K; Nakagawa H; Yamachika S; Font-Burgada J; Zhong Z; Subramaniam S; Raghunandan S; Duran A; Linares JF; Reina-Campos M; Umemura S; Valasek MA; Seki E; Yamaguchi K; Koike K; Itoh Y; Diaz-Meco MT; Moscat J; Karin M
Cancer Cell; 2016 Jun; 29(6):935-948. PubMed ID: 27211490
[TBL] [Abstract][Full Text] [Related]
3. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.
Tan CT; Soh NJH; Chang HC; Yu VC
FEBS J; 2023 Feb; 290(4):892-912. PubMed ID: 34882306
[TBL] [Abstract][Full Text] [Related]
4. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Saito T; Ichimura Y; Taguchi K; Suzuki T; Mizushima T; Takagi K; Hirose Y; Nagahashi M; Iso T; Fukutomi T; Ohishi M; Endo K; Uemura T; Nishito Y; Okuda S; Obata M; Kouno T; Imamura R; Tada Y; Obata R; Yasuda D; Takahashi K; Fujimura T; Pi J; Lee MS; Ueno T; Ohe T; Mashino T; Wakai T; Kojima H; Okabe T; Nagano T; Motohashi H; Waguri S; Soga T; Yamamoto M; Tanaka K; Komatsu M
Nat Commun; 2016 Jun; 7():12030. PubMed ID: 27345495
[TBL] [Abstract][Full Text] [Related]
5. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.
Katsuragi Y; Ichimura Y; Komatsu M
FEBS J; 2015 Dec; 282(24):4672-8. PubMed ID: 26432171
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.
Ichimura Y; Waguri S; Sou YS; Kageyama S; Hasegawa J; Ishimura R; Saito T; Yang Y; Kouno T; Fukutomi T; Hoshii T; Hirao A; Takagi K; Mizushima T; Motohashi H; Lee MS; Yoshimori T; Tanaka K; Yamamoto M; Komatsu M
Mol Cell; 2013 Sep; 51(5):618-31. PubMed ID: 24011591
[TBL] [Abstract][Full Text] [Related]
7. Role of p62/SQSTM1 in liver physiology and pathogenesis.
Manley S; Williams JA; Ding WX
Exp Biol Med (Maywood); 2013 May; 238(5):525-38. PubMed ID: 23856904
[TBL] [Abstract][Full Text] [Related]
8. SQSTM1/p62 and Hepatic Mallory-Denk Body Formation in Alcohol-Associated Liver Disease.
Qian H; Ding WX
Am J Pathol; 2023 Oct; 193(10):1415-1426. PubMed ID: 36906265
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Aigelsreiter A; Neumann J; Pichler M; Halasz J; Zatloukal K; Berghold A; Douschan P; Rainer F; Stauber R; Haybaeck J; Denk H; Lackner C
Liver Int; 2017 Apr; 37(4):600-610. PubMed ID: 27885796
[TBL] [Abstract][Full Text] [Related]
10. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Denk H; Stumptner C; Abuja PM; Zatloukal K
Expert Opin Ther Targets; 2019 May; 23(5):393-406. PubMed ID: 30987486
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy.
Chi HC; Chen SL; Tsai CY; Chuang WY; Huang YH; Tsai MM; Wu SM; Sun CP; Yeh CT; Lin KH
Autophagy; 2016 Dec; 12(12):2271-2285. PubMed ID: 27653365
[TBL] [Abstract][Full Text] [Related]
12.
Lu J; Ding Y; Zhang W; Qi Y; Zhou J; Xu N; Zhang Y; Xie W
Cells; 2023 Apr; 12(9):. PubMed ID: 37174639
[TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1/A170: physiology and pathology.
Komatsu M; Kageyama S; Ichimura Y
Pharmacol Res; 2012 Dec; 66(6):457-62. PubMed ID: 22841931
[TBL] [Abstract][Full Text] [Related]
14. Vault-phagy: a phase-separation-mediated selective autophagy of vault, a non-membranous organelle.
Kurusu R; Morishita H; Komatsu M
Autophagy; 2024 Feb; 20(2):441-442. PubMed ID: 37815214
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.
Kutlu O; Kaleli HN; Ozer E
Can J Gastroenterol Hepatol; 2018; 2018():8543763. PubMed ID: 30228976
[TBL] [Abstract][Full Text] [Related]
17. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis.
Akiyama K; Warabi E; Okada K; Yanagawa T; Ishii T; Kose K; Tokushige K; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Ariizumi SI; Yamamoto M; Shoda J
Exp Anim; 2018 May; 67(2):201-218. PubMed ID: 29276215
[TBL] [Abstract][Full Text] [Related]
18. p62/SQSTM1: 'Jack of all trades' in health and cancer.
Sánchez-Martín P; Saito T; Komatsu M
FEBS J; 2019 Jan; 286(1):8-23. PubMed ID: 30499183
[TBL] [Abstract][Full Text] [Related]
19. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.
Mildenberger J; Johansson I; Sergin I; Kjøbli E; Damås JK; Razani B; Flo TH; Bjørkøy G
Autophagy; 2017 Oct; 13(10):1664-1678. PubMed ID: 28820283
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells.
Huang H; Zhu J; Li Y; Zhang L; Gu J; Xie Q; Jin H; Che X; Li J; Huang C; Chen LC; Lyu J; Gao J; Huang C
Autophagy; 2016 Oct; 12(10):1687-1703. PubMed ID: 27467530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
